Key result
The FibriCheck smartphone app was feasible for primary care screening, detecting new atrial fibrillation in 6% (5/86) of high-risk older adults over an average of 23 days.
Why the study?
Smartphone apps measuring heart rhythm could increase AF detection in primary care, but whether introducing such an app is feasible needed assessment.
Does the FibriCheck smartphone app provide a feasible method for atrial fibrillation screening in high-risk primary care patients aged 65 or older?
Does the FibriCheck smartphone app provide a feasible method for atrial fibrillation screening in high-risk primary care patients aged 65 or older?
The FibriCheck smartphone app is a feasible, well-accepted tool for atrial fibrillation screening in high-risk older adults in primary care.
May support smartphone AF screening in primary care; leaves open need for RCTs to confirm outcomes.
BACKGROUND Atrial fibrillation (AF) is a major risk factor for stroke. The current opportunistic screening procedure consists of pulse palpation and an electrocardiogram when an irregular rhythm is found. Smartphone apps that measure heart rhythm could be useful in increasing the detection of AF in a primary care setting. OBJECTIVE We conducted a pilot study with the smartphone app FibriCheck to assess whether the introduction of such an app is feasible. METHODS Four general practices across Flanders provided patient data for the study. Inclusion criteria for participants were aged 65 or older and a CHARGE-AF score of at least 10%. We excluded patients with known AF or a pacemaker. Participants were asked to measure at least twice a day with FibriCheck (for at least 14 days). They were provided the 36-Item Short Form Survey (SF-36) questionnaire both before and after the study, as well as different surveys concerning their user experience and general perception of technology. RESULTS There were 92 participants (36 women and 56 men). The study population was relatively homogenous concerning risk factors and medication use at baseline. During the study period, 5/86 (6%) participants were found to have AF (6 dropouts). The average study period was 23 days and the average number of measurements per day was 2.1. Patient compliance was variable, but high. On the whole, there were no appreciable changes in quality of life. The overall user experience and satisfaction were very high. CONCLUSIONS FibriCheck is a relatively easy-to-use smartphone app to complement AF screening in primary care. Its implementation in this setting is certainly achievable, and one can expect high rates of patient compliance. Based on these results, a planned cluster randomized trial will be going ahead. CLINICALTRIAL ClinicalTrials.gov NCT03509493; https://clinicaltrials.gov/ct2/show/NCT03509493
No takes yet. Share an insight, caveat, or question.
Beerten et al. (2020) studied Atrial fibrillation (n=92). FibriCheck smartphone app was evaluated on Detection of atrial fibrillation. The FibriCheck smartphone app was feasible for primary care screening, detecting new atrial fibrillation in 6% (5/86) of high-risk older adults over an average of 23 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: